GERON CORP Basic Shares Outstanding (Weighted Average)
GERON CORP (GERN) reported Basic Shares Outstanding (Weighted Average) of 670.70 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- GERON CORP weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 670.70K shares, a 0.68% increase year-over-year.
- GERON CORP weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 669.38K shares, a 0.52% increase year-over-year.
- GERON CORP weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 667.46M shares, a 0.47% increase year-over-year.
- GERON CORP weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 667.10M shares, a 0.75% increase year-over-year.
- GERON CORP weighted average number of shares outstanding, basic for fiscal 2025 was 666.66M shares, a 3.19% increase from fiscal 2024.
- GERON CORP weighted average number of shares outstanding, basic for fiscal 2024 was 646.03M shares, a 13.21% increase from fiscal 2023.
- GERON CORP weighted average number of shares outstanding, basic for fiscal 2023 was 570.65M shares, a 49.86% increase from fiscal 2022.
- GERON CORP weighted average number of shares outstanding, basic for fiscal 2022 was 380.78M shares, a 16.22% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 670.70K shares 10-Q · filed 2026-08-05 | 670.04K shares 10-Q · filed 2026-08-05 | 222.93M shares derived: average of 3 quarters · filed 2026-08-05 | 333.98M shares derived: average of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | 669.38K shares 10-Q · filed 2026-05-06 | 334.07M shares derived: average of 2 quarters · filed 2026-05-06 | 445.08M shares derived: average of 3 quarters · filed 2026-05-06 | 333.97M shares derived: average of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | 667.46M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 667.28M shares derived: average of 2 quarters · filed 2026-03-02 | 445.08M shares derived: average of 3 quarters · filed 2026-08-05 | 666.66M shares 10-K · filed 2026-03-02 | ||
| 2025-09-30 | 667.10M shares 10-Q · filed 2025-11-07 | 333.88M shares derived: average of 2 quarters · filed 2026-08-05 | 666.40M shares 10-Q · filed 2025-11-07 | 333.19M shares derived: average of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | 666.17K shares 10-Q · filed 2026-08-05 | 666.17M shares 10-Q · filed 2025-08-06 | 666.04K shares 10-Q · filed 2026-08-05 | 666.04M shares 10-Q · filed 2025-08-06 | 221.89M shares derived: average of 3 quarters · filed 2026-08-05 | 331.96M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | 665.90K shares 10-Q · filed 2026-05-06 | 665.91M shares 10-Q · filed 2025-05-07 | 332.50M shares derived: average of 2 quarters · filed 2026-05-06 | 442.39M shares derived: average of 3 quarters · filed 2026-05-06 | 495.27M shares derived: average of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | 664.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 663.25M shares derived: average of 2 quarters · filed 2026-03-02 | 660.13M shares derived: average of 3 quarters · filed 2026-03-02 | 646.03M shares 10-K · filed 2026-03-02 | ||
| 2024-09-30 | 662.16M shares 10-Q · filed 2025-11-07 | 658.03M shares derived: average of 2 quarters · filed 2025-11-07 | 639.93M shares 10-Q · filed 2025-11-07 | 628.70M shares derived: average of 4 quarters · filed 2026-03-02 | ||
| 2024-06-30 | 653.90M shares 10-Q · filed 2025-08-06 | 628.70M shares 10-Q · filed 2025-08-06 | 617.55M shares derived: average of 3 quarters · filed 2026-03-02 | 608.04M shares derived: average of 4 quarters · filed 2026-03-02 | ||
| 2024-03-31 | 603.49M shares 10-Q · filed 2025-05-07 | 599.37M shares derived: average of 2 quarters · filed 2026-03-02 | 592.75M shares derived: average of 3 quarters · filed 2026-03-02 | 581.38M shares derived: average of 4 quarters · filed 2026-03-02 | ||
| 2023-12-31 | 595.24M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 587.38M shares derived: average of 2 quarters · filed 2026-03-02 | 574.01M shares derived: average of 3 quarters · filed 2026-03-02 | 570.65M shares 10-K · filed 2026-03-02 | ||
| 2023-09-30 | 579.51M shares 10-Q · filed 2024-11-07 | 563.39M shares derived: average of 2 quarters · filed 2024-11-07 | 562.45M shares 10-Q · filed 2024-11-07 | 513.10M shares derived: average of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | 547.28M shares 10-Q · filed 2024-08-08 | 553.77M shares 10-Q · filed 2024-08-08 | 490.97M shares derived: average of 3 quarters · filed 2025-02-27 | 469.53M shares derived: average of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | 544.46M shares 10-Q · filed 2024-05-02 | 462.81M shares derived: average of 2 quarters · filed 2025-02-27 | 443.62M shares derived: average of 3 quarters · filed 2025-02-27 | 433.68M shares derived: average of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | 381.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 393.20M shares derived: average of 2 quarters · filed 2025-02-27 | 396.76M shares derived: average of 3 quarters · filed 2025-02-27 | 380.78M shares 10-K · filed 2025-02-27 | ||
| 2022-09-30 | 405.24M shares 10-Q · filed 2023-11-02 | 404.55M shares derived: average of 2 quarters · filed 2023-11-02 | 380.66M shares 10-Q · filed 2023-11-02 | 368.01M shares derived: average of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | 403.87M shares 10-Q · filed 2023-08-03 | 368.17M shares 10-Q · filed 2023-08-03 | 355.60M shares derived: average of 3 quarters · filed 2024-02-28 | 348.93M shares derived: average of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | 332.07M shares 10-Q · filed 2023-05-11 | 331.47M shares derived: average of 2 quarters · filed 2024-02-28 | 330.62M shares derived: average of 3 quarters · filed 2024-02-28 | 329.72M shares derived: average of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | 330.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 329.90M shares derived: average of 2 quarters · filed 2024-02-28 | 328.94M shares derived: average of 3 quarters · filed 2024-02-28 | 327.63M shares 10-K · filed 2024-02-28 | ||
| 2021-09-30 | 328.93M shares 10-Q · filed 2022-11-07 | 327.98M shares derived: average of 2 quarters · filed 2022-11-07 | 326.55M shares 10-Q · filed 2022-11-07 | |||
| 2021-06-30 | 327.03M shares 10-Q · filed 2022-08-11 | 325.34M shares 10-Q · filed 2022-08-11 | ||||
| 2020-12-31 | 271.46M shares 10-K · filed 2023-03-16 | |||||
| 2017-12-31 | 159.22M shares 10-K · filed 2018-03-16 | |||||
| 2016-12-31 | 159.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | 159.14M shares derived: average of 2 quarters · filed 2018-03-16 | 159.05M shares 10-K · filed 2018-03-16 | |||
| 2016-09-30 | 159.14M shares 10-Q · filed 2016-11-03 | 159.01M shares 10-Q · filed 2016-11-03 | ||||
| 2015-12-31 | 158.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | 158.27M shares derived: average of 2 quarters · filed 2018-03-16 | 158.04M shares 10-K · filed 2018-03-16 | |||
| 2015-09-30 | 158.15M shares 10-Q · filed 2016-11-03 | 157.92M shares 10-Q · filed 2016-11-03 | ||||
| 2014-12-31 | 157.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | 156.99M shares derived: average of 2 quarters · filed 2017-03-01 | 153.54M shares 10-K · filed 2017-03-01 | |||
| 2014-09-30 | 156.84M shares 10-Q · filed 2015-11-05 | 152.34M shares 10-Q · filed 2015-11-05 | ||||
| 2013-12-31 | 128.38M shares 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |